n-chlorotaurine has been researched along with penicillamine in 1 studies
| Studies (n-chlorotaurine) | Trials (n-chlorotaurine) | Recent Studies (post-2010) (n-chlorotaurine) | Studies (penicillamine) | Trials (penicillamine) | Recent Studies (post-2010) (penicillamine) |
|---|---|---|---|---|---|
| 218 | 12 | 55 | 7,415 | 312 | 442 |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (100.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| McNeil, J; Shabani, F; Tippett, L | 1 |
1 other study(ies) available for n-chlorotaurine and penicillamine
| Article | Year |
|---|---|
The oxidative inactivation of tissue inhibitor of metalloproteinase-1 (TIMP-1) by hypochlorous acid (HOCI) is suppressed by anti-rheumatic drugs.
Topics: Animals; Antioxidants; Antirheumatic Agents; Auranofin; Aurothioglucose; Cell Line; Chlorocebus aethiops; Chloroquine; Collagenases; Gold Sodium Thiomalate; Humans; Hypochlorous Acid; Matrix Metalloproteinase 1; Matrix Metalloproteinase Inhibitors; Methotrexate; Neutrophils; Oxidants; Oxidation-Reduction; Penicillamine; Peptide Fragments; Peroxidase; Recombinant Fusion Proteins; Respiratory Burst; Structure-Activity Relationship; Taurine; Tissue Inhibitor of Metalloproteinase-1 | 1998 |